
Attention will shift to the resumption of US data releases. The US nonfarm payrolls data on November 20 will be significant: consensus expects 50k jobs to be added in September, up from 22k in August. Job insecurity is becoming more visible to households alongside cost-of-living concerns. The Trump administration’s messaging has increasingly emphasised inflation and affordability (price relief and tariff moderation) over direct labour market support. At the end of the US earnings season, guidance from two major corporations will be closely watched – one to provide a gauge of the consumer spending trends and margin pressure from discounting, and the other as a bellwether for sentiment on the AI trade amid worries over overvaluation.
A key overhang for markets is the wide division within the US Federal Reserve over a December rate cut. Fed Presidents John Williams (New York) and Mary Daly (San Francisco) have argued that weak demand, softer hiring, and tightening credit conditions may justify an “insurance cut.” Despite the end of the government shutdown, other Fed officials warn that available inflation data is still too limited to warrant an easing. A more apparent bias may surface after the Fed ends quantitative easing on December 1.
GBP/USD has recovered to a range of 1.31-1.32 after bottoming at 1.30 on November 5. The UK Autumn Budget, scheduled for November 26, differs from the 2022 mini-budget crisis. Chancellor Rachel Reeves has avoided a Truss-style rupture by signalling fiscal responsibility, such as keeping the Office for Budget Responsibility (OBR) engaged. Nonetheless, the Budget remains a serious challenge due to the unforgiving math: weak economic growth, high debt servicing costs, and Reeves’ self-imposed fiscal rules leave little scope to deliver public services and support economic growth without tax increases that risk dampening demand. Reeves need to recognise that blaming the past will not restore confidence and that markets like chancellors who act like stewards – predictable, accountable, and strategic in managing constraints. The IMF has already recommended more flexible fiscal rules for a weak-growth and high-interest-rate-cost environment.
USD/JPY’s rise stalled around 155 last week, capped after Japanese Finance Minister Satsuki Katayama warned that the negative effects of a weak JPY now outweigh its benefits. However, Katayama announced on Sunday that the Takaichi coalition government will submit an economic stimulus package of at least JPY17trn (USD110bn) to cushion living-cost pressures and accelerate investments in sectors such as AI and semiconductors. Funding concerns have pushed JGB yields higher, which in turn have supported USD/JPY. Approval of the package at the Diet on November 21 is not guaranteed. The LDP-Inshin coalition lacks a majority in both chambers, making support from the opposition Democratic Party for the People (DPP) essential. The direction of USD/JPY also hinges on Thursday’s US NFP report, where a softer-than-expected print could reinforce expectations for a December Fed cut and weigh on the USD, while a stronger outcome would have the opposite effect.
USD/CHF declined 1.4% to 0.7940 after the US agreed to reduce tariffs on Swiss goods to 15% from 29%. In exchange, Switzerland pledged to invest USD200bn into the US by 2028, of which USD67bn will be delivered in 2026. SNB officials signalled that the policy rate will remain unchanged at 0% in December, arguing that inflation will rise in the coming quarters while staying within the 0-2% target range. With the SNB ruling out negative rates, markets remain vigilant for FX interventions, especially with EUR/CHF at the year’s lows near 0.92 and USD/CHF below 0.80.


\
GENERAL DISCLOSURE/ DISCLAIMER (For Macroeconomics, Currencies, Interest Rates & Digital Assets)
The information herein is published by DBS Bank Ltd and/or DBS Bank (Hong Kong) Limited (each and/or collectively, the “Company”). It is based on information obtained from sources believed to be reliable, but the Company does not make any representation or warranty, express or implied, as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions expressed are subject to change without notice. This research is prepared for general circulation. Any recommendation contained herein does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. The information herein is published for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. The Company, or any of its related companies or any individuals connected with the group accepts no liability for any direct, special, indirect, consequential, incidental damages or any other loss or damages of any kind arising from any use of the information herein (including any error, omission or misstatement herein, negligent or otherwise) or further communication thereof, even if the Company or any other person has been advised of the possibility thereof. The information herein is not to be construed as an offer or a solicitation of an offer to buy or sell any securities, futures, options or other financial instruments or to provide any investment advice or services. The Company and its associates, their directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking or financial services for these companies. The information herein is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction (including but not limited to citizens or residents of the United States of America) where such distribution, publication, availability or use would be contrary to law or regulation. The information is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction (including but not limited to the United States of America) where such an offer or solicitation would be contrary to law or regulation.
[#for Distribution in Singapore] This report is distributed in Singapore by DBS Bank Ltd (Company Regn. No. 196800306E) which is Exempt Financial Advisers as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore. DBS Bank Ltd may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, DBS Bank Ltd accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact DBS Bank Ltd at 65-6878-8888 for matters arising from, or in connection with the report.
DBS Bank Ltd., 12 Marina Boulevard, Marina Bay Financial Centre Tower 3, Singapore 018982. Tel: 65-6878-8888. Company Registration No. 196800306E.
DBS Bank Ltd., Hong Kong Branch, a company incorporated in Singapore with limited liability. 18th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.
DBS Bank (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability. 11th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.
Virtual currencies are highly speculative digital "virtual commodities", and are not currencies. It is not a financial product approved by the Taiwan Financial Supervisory Commission, and the safeguards of the existing investor protection regime does not apply. The prices of virtual currencies may fluctuate greatly, and the investment risk is high. Before engaging in such transactions, the investor should carefully assess the risks, and seek its own independent advice.